Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center

Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center

Molecular Tumor Boards (MTBs) converge state-of-the-art next-generation sequencing (NGS) methods with the expertise of an interdisciplinary team consisting of clinicians, pathologists, human geneticists, and molecular biologists to provide molecularly informed guidance in clinical decision making to...

Full description

Bibliographic Details
Main Authors: Lars Tögel, Christoph Schubart, Sebastian Lettmaier, Clemens Neufert, Juliane Hoyer, Kerstin Wolff, Evgeny A Moskalev, Robert Stöhr, Abbas Agaimy, André Reis, Bernd Wullich, Andreas Mackensen, Marianne Pavel, Matthias W. Beckmann, Arndt Hartmann, Rainer Fietkau, Norbert Meidenbauer, Florian Haller, Silvia Spoerl
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
Molecular Tumor Board
clinical decision making
precision medicine
molecular pathology
real-world data
cancer care
Online Access:https://www.mdpi.com/2072-6694/15/24/5892

Internet

https://www.mdpi.com/2072-6694/15/24/5892

Similar Items